Correlation Between Dermata Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Dermata Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Dermata Therapeutics and Emergent Biosolutions
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dermata and Emergent is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 1.11 times less risky than Emergent Biosolutions. The stock trades about -0.14 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 694.00 in Emergent Biosolutions on July 20, 2025 and sell it today you would earn a total of 222.00 from holding Emergent Biosolutions or generate 31.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Dermata Therapeutics |
| Emergent Biosolutions |
Dermata Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Dermata Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Dermata Therapeutics vs. Artelo Biosciences | Dermata Therapeutics vs. Virax Biolabs Group | Dermata Therapeutics vs. Azitra Inc | Dermata Therapeutics vs. Lipella Pharmaceuticals Common |
| Emergent Biosolutions vs. Organogenesis Holdings | Emergent Biosolutions vs. Esperion Therapeutics | Emergent Biosolutions vs. Rigel Pharmaceuticals | Emergent Biosolutions vs. SIGA Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |